DelveInsight’s ‘Insulin Delivery Devices -Market Insights, Competitive Landscape and Market Forecast - 2025’ report delivers an in-depth understanding of Insulin Delivery Devices and the historical and forecasted Insulin Delivery Devices market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
The Insulin Delivery Devices market report provides an overview of Insulin Delivery Devices , reasons to get Insulin Delivery Devices as well as its advantages and limitations. Additionally, the report provides insight on the Insulin Delivery Devices market share of the individual Insulin Delivery Devices devices, current and forecasted Insulin Delivery Devices market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.
Insulin Delivery Devices Overview
Insulin, a hormone that controls blood sugar, plays a crucial function in diabetic therapy . Insulin delivery devices assist in the secretion of insulin under the skin into the fatty tissue. The overall demand increase can be due to the favourable reimbursement scenario and good government funding in selected countries, technical developments in insulin delivery devices, a rising diabetic population, and basic understanding of insulin delivery devices. Factors such as growing diabetes prevalence, increasing insulin pen usage, and government policies are projected to help the development of the demand for insulin delivery products. The rising number of diabetics due to ageing, obesity, and unhealthy lifestyles is one of the key factors leading to the market's development. It is known that obesity is a significant cause contributing to the growth of diabetes in persons. Strict regulatory legislation and regulations regulating the medication approval process and the high cost of insulin analogues in the management of diabetes treatment could however, impede the growth of the industry.
Study Period: 2017–2025
Geography Covered
• The US
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan
List of Companies:
Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (U.S.), and Insulet Corporation (U.S.). , Abbott; and F. Hoffmann-La Roche Ltd.
Insulin Delivery Devices - Competitive Analysis
This segment of the report provides a brief competitive analysis of Insulin Delivery Devices , to help understand the competition in the market. It gives a comparative understanding of the products based on types of wounds.
Insulin Delivery Devices : Market Analysis
This segment illustrates the market of Insulin Delivery Devices across 7MM and how the market is expected to rise in the study period (2017 to 2025), at a significant CAGR.
KOL- Views
To keep up with the market trends, we take KOLs and SME’s opinion working in Insulin Delivery Devices domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Insulin Delivery Devices market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.
Scope of the Report
• The report covers the descriptive overview of Insulin Delivery Devices , explaining its applications, advantages, and limitations, etc.
• Additionally, an all-inclusive account of the currently available Insulin Delivery Devices is provided, which will have an impact on the future market of Insulin Delivery Devices .
• A detailed review of Insulin Delivery Devices market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Insulin Delivery Devices market.
Report Highlights
• The report covers descriptive overview of the Insulin Delivery Devices , explaining its applications, working mechanism, etc.
• The report provides an insight into the patient population eligible for Insulin Delivery Devices in the 7 MM, covering the US, EU5 (Germany, Spain, France, Italy, UK) & Japan.
• The report is a comprehensive account of marketed devices present in the Insulin Delivery Devices market.
• The report also reviews the detailed global historical and forecasted Insulin Delivery Devices market including assessing the outreach in 7 MM.
• The report helps in developing business strategies by understanding trends shaping and driving the global Insulin Delivery Devices market.
Insulin Delivery Devices Report Key Strengths
• 6 Years Forecast
• 7MM Coverage
• Competitive Landscape
• Patient pool
• Market Size
Insulin Delivery Devices Report Assessment
• Marketed Product profiles
• Key Products and Key Players
• Market Drivers and Barriers
• Market Forecast
• KOL’S views
Key Questions
Market Insights:
• What was the Insulin Delivery Devices market share (%) distribution in 2017 and how it will look like in 2025?
• What will be the Insulin Delivery Devices total market Size as well as market Size by devices across the 7MM during the forecast period (2017–2025)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Insulin Delivery Devices market Size during the forecast period (2017–2025)?
• At what CAGR, the Insulin Delivery Devices market is expected to grow in 7mm during the forecast period (2017–2025)?
• What will be the Insulin Delivery Devices market outlook across the 7mm during the forecast period (2017–2025)?
• What will be the Insulin Delivery Devices market growth till 2025 and what will be the resultant market size in the year 2025?
• How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?
Competitive Landscape:
• What are the current devices available in the Insulin Delivery Devices market?
• What is the Insulin Delivery Devices available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
• How many key players are developing Insulin Delivery Devices ?
• What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Insulin Delivery Devices ?
• What are the key designations that have been granted for the current Insulin Delivery Devices ?
• What are the global historical and forecasted market of Insulin Delivery Devices ?
'
1. Key Insights
2. Executive Summary of Insulin Delivery Devices
3. Insulin Delivery Devices : Background and Overview
3.1. Introduction
4. Company Profiles
4.1. Company A
4.1.1. Company Overview
4.1.2 Product Portfolio
4.1.2.1 Product description
4.1.2.2 Regulatory Milestones
4.1.2.3 Research and Development
4.1.2.4 Product Development Activities
4.2. Company B
4.2.1.Company Overview
4.2.2 Product Portfolio
4.2.2.1 Product description
4.2.2.2 Regulatory Milestones
4.2.2.3 Research and Development
4.2.2.4 Product Development Activities
Products detail in the report…
5 Insulin Delivery Devices : Competitive Analysis
6. Insulin Delivery Devices Devices: Market Analysis
6.1. Insulin Delivery Devices : Market Analysis in the 7MM (2017–2025)
6.1.1. Insulin Delivery Devices : Market Analysis in the 7MM by type (2017–2025)
6.1.2. Insulin Delivery Devices : Market Analysis in the 7MM by application (2017–2025)
6.1.3. Insulin Delivery Devices : Market Analysis in the 7MM by end user (2017–2025)
6.2. Insulin Delivery Devices : United States Market Analysis (2017–2025)
6.2.1. Insulin Delivery Devices : Market Analysis in the US by type (2017-2025)
6.2.2. Insulin Delivery Devices : Market Analysis in the US by application (2017-2025)
6.2.3. Insulin Delivery Devices : Market Analysis in the US by end user (2017-2025)
6.3. Insulin Delivery Devices : Germany Market Analysis (2017–2025)
6.3.1. Insulin Delivery Devices : Market Analysis in Germany by type (2017-2025)
6.3.2. Insulin Delivery Devices : Market Analysis in Germany by application (2017-2025)
6.3.3. Insulin Delivery Devices : Market Analysis in Germany by end user (2017-2025)
6.4. Insulin Delivery Devices : France Market Analysis (2017–2025)
6.3.1. Insulin Delivery Devices : Market Analysis in France by type (2017-2025)
6.3.2. Insulin Delivery Devices : Market Analysis in France by application (2017-2025)
6.3.3. Insulin Delivery Devices : Market Analysis in France by end user (2017-2025)
6.5. Insulin Delivery Devices : Italy Market Analysis (2017–2025)
6.5.1. Insulin Delivery Devices : Market Analysis in Italy by type (2017-2025)
6.5.2. Insulin Delivery Devices : Market Analysis in Italy by application (2017-2025)
6.5.3. Insulin Delivery Devices : Market Analysis in Italy by end user (2017-2025)
6.6. Insulin Delivery Devices : Spain Market Analysis (2017–2025)
6.6.1. Insulin Delivery Devices : Market Analysis in Spain by type (2017-2025)
6.6.2. Insulin Delivery Devices : Market Analysis in Spain by application (2017-2025)
6.6.3. Insulin Delivery Devices : Market Analysis in Spain by end user (2017-2025)
6.7. Insulin Delivery Devices : United Kingdom Market Analysis (2017–2025)
6.7.1. Insulin Delivery Devices : Market Analysis in the UK by type (2017-2025)
6.7.2. Insulin Delivery Devices : Market Analysis in the UK by application (2017-2025)
6.7.3. Insulin Delivery Devices : Market Analysis in the UK by end user (2017-2025)
6.8. Insulin Delivery Devices : Japan Market Analysis (2017–2025)
6.8.1. Insulin Delivery Devices : Market Analysis in Japan by type (2017-2025)
6.8.2. Insulin Delivery Devices : Market Analysis in Japan by application (2017-2025)
6.8.3. Insulin Delivery Devices : Market Analysis in Japan by end user (2017-2025)
7. Market Drivers
8. Market Barriers
9. Industry Trends
10. KOL’s Views
11. Analyst Views
12. PEST Analysis
13. Appendix
13.1. Bibliography
13.2. Report Methodology
14. DelveInsight Capabilities
15. Disclaimer
16. About DelveInsight
Table 1: Competitive Analysis
Table 2: Insulin Delivery Devices : Market Analysis in the 7MM (2017–2025)
Table 3: Insulin Delivery Devices : Market Analysis in the 7MM by type (2017–2025)
Table 4: Insulin Delivery Devices : Market Analysis in the 7MM by application (2017–2025)
Table 5: Insulin Delivery Devices : Market Analysis in the 7MM by end user (2017–2025)
Table 6: Insulin Delivery Devices : United States Market Analysis (2017–2025)
Table 7: Insulin Delivery Devices : Market Analysis in the US by type (2017-2025)
Table 8: Insulin Delivery Devices : Market Analysis in the US by application (2017-2025)
Table 9: Insulin Delivery Devices : Market Analysis in the US by end user (2017-2025)
Table 10: Insulin Delivery Devices : Germany Market Analysis (2017–2025)
Table 11: Insulin Delivery Devices : Market Analysis in Germany by type (2017-2025)
Table 12: Insulin Delivery Devices : Market Analysis in Germany by application (2017-2025)
Table 13: Insulin Delivery Devices : Market Analysis in Germany by end user (2017-2025)
Table 14: Insulin Delivery Devices : France Market Analysis (2017–2025)
Table 15: Insulin Delivery Devices : Market Analysis in France by type (2017-2025)
Table 16: Insulin Delivery Devices : Market Analysis in France by application (2017-2025)
Table 17: Insulin Delivery Devices : Market Analysis in France by end user (2017-2025)
Table 18: Insulin Delivery Devices : Italy Market Analysis (2017–2025)
Table 19: Insulin Delivery Devices : Market Analysis in Italy by type (2017-2025)
Table 20: Insulin Delivery Devices : Market Analysis in Italy by application (2017-2025)
Table 21: Insulin Delivery Devices : Market Analysis in Italy by end user (2017-2025)
Table 22: Insulin Delivery Devices : Spain Market Analysis (2017–2025)
Table 23: Insulin Delivery Devices : Market Analysis in Spain by type (2017-2025)
Table 24: Insulin Delivery Devices : Market Analysis in Spain by application (2017-2025)
Table 25: Insulin Delivery Devices : Market Analysis in Spain by end user (2017-2025)
Table 26: Insulin Delivery Devices : United Kingdom Market Analysis (2017–2025)
Table 27: Insulin Delivery Devices : Market Analysis in the UK by type (2017-2025)
Table 28: Insulin Delivery Devices : Market Analysis in the UK by application (2017-2025)
Table 29: Insulin Delivery Devices : Market Analysis in the UK by end user (2017-2025)
Table 30: Insulin Delivery Devices : Japan Market Analysis (2017–2025)
Table 31: Insulin Delivery Devices : Market Analysis in Japan by type (2017-2025)
Table 32: Insulin Delivery Devices : Market Analysis in Japan by application (2017-2025)
Table 33: Insulin Delivery Devices : Market Analysis in Japan by end user (2017-2025)
Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (U.S.), and Insulet Corporation (U.S.). , Abbott; and F. Hoffmann-La Roche Ltd.
